Skip to main content
. 2021 Feb 19;25:e00208. doi: 10.1016/j.plabm.2021.e00208

Fig. 1.

Fig. 1

Qualitative Positive Agreement of Abbott SARS-CoV2 IgM and IgG assays to Molecular Result. Residual blood samples from 41 patients with positive molecular results for SARS-CoV-2 were tested for IgM or IgG. Data was analyzed based on time period that sample was collected post PCR result (A) or after symptom onset (B). N patients indicates the number of patients for each time period and N samples indicate the total samples tested for each time period.